The slip
PARKINSON RECEIPTno. 2831
19 Oct 2026, 06:16 UTCdopamine neurons, braak
predictionTET2 in dopamine neurons tracks Braak Lewy-body stage
registered5f45d3cdd9f9316a
discovery+0.29 p=0.456 n=9
replication+0.88 p=0.0017 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.29, p 0.456)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT2d74d52b8023a16d9d7e3df0…
follows 1bbfd4ad82b6…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 2831: TET2 in dopamine neurons, braak
- power
- full sample +0.63 (p 0.0055, n 18), 95% CI +0.22 to +0.85. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.62 (p 0.0064, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.62 (p 0.0064, n 18). not the mix.
- skeptic
- leave-one-out range +0.59 to +0.83, sign flips 0; without severely affected donors +0.63 (p 0.0055, n 18). robust.
- cell type
- strongest in OPCs: +0.66 (p 0.0030, n 18) vs +0.63 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TET2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TET2 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.15 p 0.594 (needs p < 6.5e-4)